These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9678442)

  • 61. Antiviral treatment in acute hepatitis C.
    Macedo G; Correia A; Ribeiro T
    Hepatogastroenterology; 2003; 50(52):1057-9. PubMed ID: 12845981
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical manifestations and effect of early therapy with interferon-alpha on the course of acute hepatitis C].
    Warunek W; Cieśla A; Zejc-Bajsarowicz M; Janas-Skulina U; Mach T
    Przegl Epidemiol; 2005; 59(2):467-74. PubMed ID: 16190555
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Can oseltamivir (Tamiflu) be used in dialysis-requiring renal failure?].
    Rosenborg S
    Lakartidningen; 2010 Jan 20-26; 107(3):116-7. PubMed ID: 20225688
    [No Abstract]   [Full Text] [Related]  

  • 64. Comparative efficacy of a high or low dose of interferon alpha 2b in chronic hepatitis C: a randomized controlled trial.
    Tassopoulos NC; Karvountzis G; Touloumi G; Delladetsima JK; Papatheodoridis GV; Katsoulidou A; Retalis G; Hatzakis A
    Am J Gastroenterol; 1996 Sep; 91(9):1734-8. PubMed ID: 8792690
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C.
    Vigani AG; Pavan MH; Tozzo R; Gonçales ES; Lazarini MS; Oliveira AM; Gonçales FL
    Braz J Infect Dis; 2010; 14(2):193-6. PubMed ID: 20563450
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Acute hepatitis C: dosage and compliance.
    De Rosa F; Cariti G; Di Perri G
    Hepatology; 2006 Aug; 44(2):511; author reply 511-2. PubMed ID: 16871564
    [No Abstract]   [Full Text] [Related]  

  • 67. Pegylated interferon-alpha-based treatment for chronic hepatitis C in renal transplant recipients: an open pilot study.
    Pageaux GP; Hilleret MN; Garrigues V; Bismuth M; Audin-Mamlouk H; Zarski JP; Mourad G
    Transpl Int; 2009 May; 22(5):562-7. PubMed ID: 19175562
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.
    Kokoglu OF; Uçmak H; Hosoglu S; Cetinkaya A; Kantarceken B; Buyukbese MA; Isik IO
    J Gastroenterol Hepatol; 2006 Mar; 21(3):575-80. PubMed ID: 16638102
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interferon alpha monotherapy for chronic hepatitis C viral infection in thalassemics and hemodialysis patients.
    Artan R; Akcam M; Yilmaz A; Kocacik D
    J Chemother; 2005 Dec; 17(6):651-5. PubMed ID: 16433196
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy.
    Deltenre P; Moreno C; Tran A; Ollivier I; Provôt F; Stanke F; Lazrek M; Castel H; Canva V; Louvet A; Colin M; Glowacki F; Dharancy S; Henrion J; Hazzan M; Noel C; Mathurin P
    Aliment Pharmacol Ther; 2011 Aug; 34(4):454-61. PubMed ID: 21682756
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lack of sustained efficacy of interferon in patients with chronic hepatitis C.
    Vento S; Concia E; Ferraro T
    N Engl J Med; 1996 May; 334(22):1479-80. PubMed ID: 8618600
    [No Abstract]   [Full Text] [Related]  

  • 72. Treatment of chronic hepatitis B and hepatitis C with interferon alfa-2b.
    Molloy PJ; Azzouz M; Van Thiel DH
    Am Fam Physician; 1996 Oct; 54(5):1598-605. PubMed ID: 8857782
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients.
    Bruchfeld A; Lindahl K; Reichard O; Carlsson T; Schvarcz R
    J Viral Hepat; 2006 May; 13(5):316-21. PubMed ID: 16637862
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Occult hepatitis C virus infection in dialysis patients: does it need special attention?
    Rezaee-Zavareh MS; Ramezani-Binabaj M; Einollahi B
    Saudi J Kidney Dis Transpl; 2015 Mar; 26(2):368-9. PubMed ID: 25758893
    [No Abstract]   [Full Text] [Related]  

  • 75. Hepatitis C: is isolation essential?
    al Shohaib S; Abunijem Z
    Nephron; 1996; 73(1):109. PubMed ID: 8742974
    [No Abstract]   [Full Text] [Related]  

  • 76. Consensus panel advocates prolonged interferon treatment for chronic hepatitis C.
    Am J Health Syst Pharm; 1997 May; 54(10):1140, 1145. PubMed ID: 9161619
    [No Abstract]   [Full Text] [Related]  

  • 77. Management of hepatitis C in patients with chronic kidney disease.
    Carvalho-Filho RJ; Feldner AC; Silva AE; Ferraz ML
    World J Gastroenterol; 2015 Jan; 21(2):408-22. PubMed ID: 25593456
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy of interferon alpha in acute hepatitis C in patients on chronic hemodialysis.
    Süleymanlar I; Sezer T; Işitan F; Yakupoglu G; Süleymanlar G
    Nephron; 1998; 79(3):353-4. PubMed ID: 9678442
    [No Abstract]   [Full Text] [Related]  

  • 79. Treatment of chronic hepatitis C with interferon alpha in patients on maintenance hemodialysis.
    Djordjević V; Kostić S; Stefanović V
    Nephron; 1998; 79(2):229-31. PubMed ID: 9647511
    [No Abstract]   [Full Text] [Related]  

  • 80. [Treatment of hepatitis C with interferon-alpha in hemodialysis patients].
    Degos F
    Nephrologie; 1997; 18(7):279-80. PubMed ID: 9496567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.